Giuliana M. Carlos
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
In vivo reflectance confocal microscopy can detect the invasive component of lentigo maligna melanoma: Prospective analysis and case-control study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: September 24, 2022
Incidence of Basal Cell Carcinoma and Squamous Cell Carcinoma in Patients on Antiprogrammed Cell Death-1 Therapy for Metastatic Melanoma.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: June 26, 2018
Drug reaction with eosinophilia and systemic symptoms in metastatic basal cell carcinoma treated with vismodegib.
Journal: The Australasian journal of dermatology
Published: February 15, 2017
Histologic Assessment of Lichenoid Dermatitis Observed in Patients With Advanced Malignancies on Antiprogramed Cell Death-1 (anti-PD-1) Therapy With or Without Ipilimumab.
Journal: The American Journal of dermatopathology
Published: January 04, 2017
Melanocytic lesion evolution patterns with targeted therapies and immunotherapies for advanced metastatic melanoma: An observational study.
Journal: The Australasian journal of dermatology
Published: October 03, 2016
Accuracy of optical coherence tomography for the diagnosis of superficial basal cell carcinoma: a prospective, consecutive, cohort study of 168 cases.
Journal: The British journal of dermatology
Published: April 29, 2016
Bullous pemphigoid, an autoantibody-mediated disease, is a novel immune-related adverse event in patients treated with anti-programmed cell death 1 antibodies.
Journal: Melanoma research
Published: April 01, 2016
Ipilimumab-induced acute generalized exanthematous pustulosis in a patient with metastatic melanoma.
Ipilimumab-induced acute generalized exanthematous pustulosis in a patient with metastatic melanoma.
Journal: Melanoma research
Published: April 01, 2016
Cutaneous Adverse Events of New Anti-melanoma Therapies: Classification and Management.
Journal: Actas dermo-sifiliograficas
Published: February 23, 2016
Mechanisms of BRAFi-induced hyperproliferative cutaneous conditions.
Journal: Experimental dermatology
Published: February 09, 2016
Cutaneous adverse events (AEs) of anti-programmed cell death (PD)-1 therapy in patients with metastatic melanoma: A single-institution cohort.
Journal: Journal of the American Academy of Dermatology
Published: July 24, 2015
Last Updated: 09/26/2026